Loui, Hollyann F.
Li, Joshua
Jackson, Nicholas J.
Romero, Ruby
Wisk, Lauren E.
Buhr, Russell G.
Article History
Received: 10 July 2023
Accepted: 2 October 2024
First Online: 15 October 2024
Declarations
:
: This study was reviewed and approved by the University of California, Los Angeles Institutional Review Board (20–000683). All methods were carried out in accordance with relevant guidelines and regulations. All participants provided electronically signed informed consent.
: Not applicable.
: Dr. Buhr reports prior personal consulting fees for Viatris/Theravance Biopharma, Chiesi, 2ndMD, and DynaMed/American College of Physicians unrelated to this work and is an employee of the Veterans Health Administration. The views and positions in this manuscript do not necessarily reflect those of the Department of Veterans Affairs or United States Government. Drs. Loui, Wisk, and Jackson, Ms. Romero, and Mr. Li report nothing to disclose.